Congenital Heart Defects and Indices of Fetal Cerebral Growth in a Nationwide Cohort of 924 422 Liveborn Infants

Circulation

Volumn 133, Issue 6, 2016, Pages 566-575

  Matthiesen, Niels B ^a   Henriksen, Tine B ^a   Gaynor, J William ^b   Agergaard, Peter ^a   Bach, Cathrine C ^a   Hjortdal, Vibeke E ^a   Østergaard, John R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

brain; epidemiology; heart defects, congenital; pediatrics

Indexed keywords

AORTA ARCH ANOMALY; AORTA COARCTATION; AORTA STENOSIS; ARTERIAL TRUNK; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BRAIN DEVELOPMENT; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; FALLOT TETRALOGY; GESTATIONAL AGE; GREAT VESSELS TRANSPOSITION; HEAD CIRCUMFERENCE; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LIVE BIRTH; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEWBORN; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; RISK ASSESSMENT; RISK FACTOR; ADULT; BRAIN; DENMARK; EMBRYOLOGY; FEMALE; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; HEART DEFECTS, CONGENITAL; MALE; PHYSIOLOGY; PREGNANCY;

ADULT; BRAIN; COHORT STUDIES; DENMARK; FEMALE; FETAL DEVELOPMENT; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY;

EID: 84957845676     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.019089     Document Type: Article

References (50)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.
2. Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123:841-849. doi: 10.1161/CIRCULATIONAHA.110.958405.
3. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254-2263. doi: 10.1161/CIRCULATIONAHA.110.947002.
4. Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C. Neurologic status of newborns with congenital heart defects before open heart surgery. Pediatrics. 1999;103:402-408.
5. Gaynor JW, Stopp C, Wypij D, Andropoulos DB, Atallah J, Atz AM, Beca J, Donofrio MT, Duncan K, Ghanayem NS, Goldberg CS, Hövels-Gürich H, Ichida F, Jacobs JP, Justo R, Latal B, Li JS, Mahle WT, McQuillen PS, Menon SC, Pemberton VL, Pike NA, Pizarro C, Shekerdemian LS, Synnes A, Williams I, Bellinger DC, Newburger JW; International Cardiac Collaborative on Neurodevelopment (ICCON) Investigators. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2015;135:816-825. doi: 10.1542/peds.2014-3825.
6. Bellinger DC, Wypij D, duPlessis AJ, Rappaport LA, Jonas RA, Wernovsky G, Newburger JW. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003;126:1385-1396. doi: 10.1016/S0022.
7. Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr, Guizard N, McGrath E, Geva J, Annese D, Dunbar-Masterson C, Trainor B, Laussen PC, du Plessis AJ. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation. 2010;121:26-33. doi: 10.1161/CIRCULATIONAHA.109.865568.
8. Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126:1143-1172. doi: 10.1161/CIR.0b013e318265ee8a.
9. Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, Zackai E, Nord AS, Clancy RR, Nicolson SC, Spray TL. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg. 2007;133:1344-53, 1353.e1. doi: 10.1016/j.jtcvs.2006.10.087.
10. Matos SM, Sarmento S, Moreira S, Pereira MM, Quintas J, Peixoto B, Areias JC, Areias ME. Impact of fetal development on neurocognitive performance of adolescents with cyanotic and acyanotic congenital heart disease. Congenit Heart Dis. 2014;9:373-381. doi: 10.1111/chd.12152.
11. Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg. 2009;137:529-536; discussion 536. doi: 10.1016/j.jtcvs.2008.10.025.
12. Miller SP, McQuillen PS, Hamrick S, Xu D, Glidden DV, Charlton N, Karl T, Azakie A, Ferriero DM, Barkovich AJ, Vigneron DB. Abnormal brain development in newborns with congenital heart disease. N Engl J Med. 2007;357:1928-1938. doi: 10.1056/NEJMoa067393.
13. Donofrio MT, Bremer YA, Schieken RM, Gennings C, Morton LD, Eidem BW, Cetta F, Falkensammer CB, Huhta JC, Kleinman CS. Autoregulation of cerebral blood flow in fetuses with congenital heart disease: the brain sparing effect. Pediatr Cardiol. 2003;24:436-443. doi: 10.1007/s00246-002-0404-0.
14. Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, Grosse-Wortmann L, Jaeggi E, McCrindle BW, Kingdom J, Hickey E, Miller S, Seed M. Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation. 2015;131:1313-1323. doi: 10.1161/CIRCULATIONAHA.114.013051.
15. Rosenthal GL. Patterns of prenatal growth among infants with cardiovascular malformations: possible fetal hemodynamic effects. Am J Epidemiol. 1996;143:505-513.
16. Masoller N, Martínez JM, Gómez O, Bennasar M, Crispi F, Sanz-Cortés M, Eganã-Ugrinovic G, Bartrons J, Puerto B, Gratacós E. Evidence of second-trimester changes in head biometry and brain perfusion in fetuses with congenital heart disease. Ultrasound Obstet Gynecol. 2014;44:182-187. doi: 10.1002/uog.13373.
17. Yamamoto Y, Khoo NS, Brooks PA, Savard W, Hirose A, Hornberger LK. Severe left heart obstruction with retrograde arch flow influences fetal cerebral and placental blood flow. Ultrasound Obstet Gynecol. 2013;42:294-299. doi: 10.1002/uog.12448.
18. Zeng S, Zhou QC, Zhou JW, Li M, Long C, Peng QH. Volume of intracranial structures on three-dimensional ultrasound in fetuses with congenital heart disease. Ultrasound Obstet Gynecol. 2015;46:174-181. doi: 10.1002/uog.14677.
19. McElhinney DB, Benson CB, Brown DW, Wilkins-Haug LE, Marshall AC, Zaccagnini L, Tworetzky W. Cerebral blood flow characteristics and biometry in fetuses undergoing prenatal intervention for aortic stenosis with evolving hypoplastic left heart syndrome. Ultrasound Med Biol. 2010;36:29-37. doi: 10.1016/j.ultrasmedbio.2009.09.004.
20. Shillingford AJ, Ittenbach RF, Marino BS, Rychik J, Clancy RR, Spray TL, Gaynor JW, Wernovsky G. Aortic morphometry and microcephaly in hypoplastic left heart syndrome. Cardiol Young. 2007;17:189-195. doi: 10.1017/S1047951107000248.
21. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541-549. doi: 10.1007/s10654-014-9930-3.
22. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45:320-323.
23. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 suppl):30-33. doi: 10.1177/1403494811401482.
24. Agergaard P, Olesen C, ∅stergaard JR, Christiansen M, Sørensen KM. The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based study. Am J Med Genet A. 2012;158A:498-508. doi: 10.1002/ajmg.a.34250.
25. Agergaard P, Hebert A, Bjerre J, Sørensen KM, Olesen C, Ostergaard JR. Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient Registry. Clin Epidemiol. 2011;3:61-66. doi: 10.2147/CLEP.S15627.
26. Olsen M, Sørensen HT, Hjortdal VE, Christensen TD, Pedersen L. Congenital heart defects and developmental and other psychiatric disorders: a Danish nationwide cohort study. Circulation. 2011;124:1706-1712. doi: 10.1161/CIRCULATIONAHA.110.002832.
27. Jørgensen FS. [Ultrasonography of pregnant women in Denmark 1999-2000. Description of the development since 1980-1990]. Ugeskr Laeger. 2003;165:4409-4415.
28. Talge NM, Mudd LM, Sikorskii A, Basso O. United States birth weight reference corrected for implausible gestational age estimates. Pediatrics. 2014;133:844-853. doi: 10.1542/peds.2013-3285.
29. Mølgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013;369:830-839. doi: 10.1056/NEJMoa1301066.
30. European Surveillance of Congenital Anomalies. Guide 1.3: Instructions for the Registration and Surveillance of Congenital Anomalies. 2009. http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf. Accessed August 15, 2015.
31. Deleted in proof.
32. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37-48.
33. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
34. Wilcox AJ, Weinberg CR, Basso O. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol. 2011;174:1062-1068. doi: 10.1093/aje/kwr230.
35. Susser E, Eide MG, Begg M. Invited commentary: the use of sibship studies to detect familial confounding. Am J Epidemiol. 2010;172:537-539. doi: 10.1093/aje/kwq196.
36. Svensson E, Ehrenstein V, Nørgaard M, Bakketeig LS, Rothman KJ, Sørensen HT, Pedersen L. Estimating the proportion of all observed birth defects occurring in pregnancies terminated by a second-trimester abortion. Epidemiology. 2014;25:866-871. doi: 10.1097/EDE.0000000000000163.
37. Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99:490-496.
38. Stoll C, Alembik Y, Roth MP, Dott B, De Geeter B. Risk factors in congenital heart disease. Eur J Epidemiol. 1989;5:382-391.
39. Szwast A, Tian Z, McCann M, Soffer D, Rychik J. Comparative analysis of cerebrovascular resistance in fetuses with single-ventricle congenital heart disease. Ultrasound Obstet Gynecol. 2012;40:62-67. doi: 10.1002/uog.11147.
40. Gaynor JW, Gerdes M, Nord AS, Bernbaum J, Zackai E, Wernovsky G, Clancy RR, Heagerty PJ, Solot CB, McDonald-McGinn D, Jarvik GP. Is cardiac diagnosis a predictor of neurodevelopmental outcome after cardiac surgery in infancy? J Thorac Cardiovasc Surg. 2010;140:1230-1237. doi: 10.1016/j.jtcvs.2010.07.069.
41. Barbu D, Mert I, Kruger M, Bahado-Singh RO. Evidence of fetal central nervous system injury in isolated congenital heart defects: microcephaly at birth. Am J Obstet Gynecol. 2009;201:431-437. doi: 10.1016/j. ajog.2009.03.029.
42. Williams IA, Fifer C, Jaeggi E, Levine JC, Michelfelder EC, Szwast AL. The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease. Am Heart J. 2013;165:544-550.e1. doi: 10.1016/j.ahj.2012.11.013.
43. Arduini M, Rosati P, Caforio L, Guariglia L, Clerici G, Di Renzo GC, Scambia G. Cerebral blood flow autoregulation and congenital heart disease: possible causes of abnormal prenatal neurologic development. J Matern Fetal Neonatal Med. 2011;24:1208-1211. doi: 10.3109/14767058.2010.547961.
44. Cooke RW, Lucas A, Yudkin PL, Pryse-Davies J. Head circumference as an index of brain weight in the fetus and newborn. Early Hum Dev. 1977;1:145-149.
45. Cheong JL, Hunt RW, Anderson PJ, Howard K, Thompson DK, Wang HX, Bear MJ, Inder TE, Doyle LW. Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics. 2008;121:e1534-e1540. doi: 10.1542/peds.2007-2671.
46. Munakata S, Okada T, Okahashi A, Yoshikawa K, Usukura Y, Makimoto M, Hosono S, Takahashi S, Mugishima H, Okuhata Y. Gray matter volumetric MRI differences late-preterm and term infants. Brain Dev. 2013;35:10-16. doi: 10.1016/j.braindev.2011.12.011.
47. Brossard-Racine M, du Plessis AJ, Vezina G, Robertson R, Bulas D, Evangelou IE, Donofrio M, Freeman D, Limperopoulos C. Prevalence and spectrum of in utero structural brain abnormalities in fetuses with complex congenital heart disease. AJNR Am J Neuroradiol. 2014;35:1593-1599. doi: 10.3174/ajnr.A3903.
48. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003;14:300-306.
49. Kaltman JR, Jarvik GP, Bernbaum J, Wernovsky G, Gerdes M, Zackai E, Clancy RR, Nicolson SC, Spray TL, Gaynor JW. Neurodevelopmental outcome after early repair of a ventricular septal defect with or without aortic arch obstruction. J Thorac Cardiovasc Surg. 2006;131:792-798. doi: 10.1016/j.jtcvs.2005.12.023.
50. Simons JS, Glidden R, Sheslow D, Pizarro C. Intermediate neurodevelopmental outcome after repair of ventricular septal defect. Ann Thorac Surg. 2010;90:1586-1591. doi: 10.1016/j.athoracsur.2010.06.082.